NCT07599878 Adjunctive Group Psychotherapy for Moderate-to-Severe Atopic Dermatitis: A Pilot Feasibility Study Comparing Two Interventions Status COMPLETED Phase NA
NCT07599813 A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis Status RECRUITING Phase PHASE2
NCT07598383 A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis Status NOT_YET_RECRUITING Phase PHASE2
NCT07592585 Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis Status NOT_YET_RECRUITING Phase PHASE3
NCT07577921 Evaluation of the Efficacy of a Cosmetic Care in Subjects With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments Status COMPLETED Phase N/A
NCT07560618 Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream. Status NOT_YET_RECRUITING Phase PHASE4
NCT07559773 The ROOT Study: Scaling the 'Standard of Care Plus' Obstetric Nutrition Model to Optimize Maternal and Infant Health Status NOT_YET_RECRUITING Phase NA
NCT07549984 A Study of IBI3033 in Moderate-to-Severe Atopic Dermatitis Status NOT_YET_RECRUITING Phase PHASE1
NCT07549828 Sebum Metabolomics and Lipidomics for Clinical Applications Status NOT_YET_RECRUITING Phase NA
NCT07549750 A Dose Escalation Phase 1 Study of HXN5003 in Healthy Participants Status NOT_YET_RECRUITING Phase PHASE1
NCT07537751 Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic Dermatitis Status COMPLETED Phase NA
NCT07533851 A Food Effect Study of VC005 Tablets in Healthy Adult Subjects. Status NOT_YET_RECRUITING Phase PHASE1
NCT07527923 First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis Status NOT_YET_RECRUITING Phase PHASE1
NCT07519174 A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks Status NOT_YET_RECRUITING Phase NA
NCT07488065 A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants Status RECRUITING Phase PHASE1
NCT07479615 A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis Status NOT_YET_RECRUITING Phase PHASE3
NCT07467564 The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis Status RECRUITING Phase N/A
NCT07448363 Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica Status NOT_YET_RECRUITING Phase N/A